
A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations
Keywords: آنفلوانزا ; MN; microneutralisation; HI; haemagglutination inhibition; CHMP; European Committee for Medicinal Products for Human Use; AE; adverse event; SAE; serious adverse event; GMR; geometric mean ratio; GMT; geometric mean titre; Influenza; H1N1; Pandemic; Adjuv